PIK3CA and breast cancer: Thus, considering the high frequency of PIK3CA gene alterations in breast cancer (more than 25% of all breast malignancies), the discovery of alpelisib was of great importance for many patients, proving that detecting genomic alterations is crucial, as research in the past decade has been mainly focused on developing new drugs targeting such molecular aberrations [49].